Lead party: Balaxi Global DMCC (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Balaxi Healthcare Angola (SU) LDA (private company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Angola
Transaction type: Merger/Acquisition(M&A) · Asset class: Corporate Transactions · Strategy: Buyout · Instrument: Equity · Deal amount: US$650,000 · Equity stake: 0.51% · Implied EV: US$1.3m
Lead investor/buyer: Balaxi Global DMCC · Investors/buyers: Balaxi Global DMCC
Legal advisers: not identified in the source record.
Source: announced 1 January 2022. Original announcement: stockdiscovery.s3.amazonaws.com.


